scholarly article | Q13442814 |
P819 | ADS bibcode | 2011PLoSO...627289W |
P356 | DOI | 10.1371/JOURNAL.PONE.0027289 |
P932 | PMC publication ID | 3210778 |
P698 | PubMed publication ID | 22087281 |
P5875 | ResearchGate publication ID | 51800473 |
P2093 | author name string | Zhou Zhou | |
Li Wang | |||
Yue Sun | |||
Baihua Shen | |||
Jinpiao Lin | |||
Ningli Li | |||
Rongfen Huo | |||
P2860 | cites work | T helper 17 cells promote cytotoxic T cell activation in tumor immunity | Q24646584 |
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells | Q27860460 | ||
Transforming growth factor-beta induces development of the T(H)17 lineage | Q28237370 | ||
IL-23 promotes tumour incidence and growth | Q28239522 | ||
TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells | Q28296956 | ||
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation | Q29547525 | ||
The regulation of IL-10 production by immune cells | Q29615479 | ||
Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism. | Q52014124 | ||
Chemokines and the arrest of lymphocytes rolling under flow conditions. | Q52040689 | ||
Quantitative analysis of chemokine expression by dendritic cell subsets in vitro and in vivo | Q73894243 | ||
The plasticity of dendritic cell responses to pathogens and their components | Q77069892 | ||
Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells | Q78806915 | ||
Immunization with autologous T cells enhances in vivo anti-tumor immune responses accompanied by up-regulation of GADD45beta | Q79853276 | ||
Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells | Q80466965 | ||
The prevalence of Th17 cells in patients with gastric cancer | Q81700421 | ||
TGF-beta 1 uses distinct mechanisms to inhibit IFN-gamma expression in CD4+ T cells at priming and at recall: differential involvement of Stat4 and T-bet | Q81724302 | ||
Taming regulatory T cells by autologous T cell immunization: a potential new strategy for cancer immune therapy | Q84089723 | ||
Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer | Q84174874 | ||
T helper 17 T cells do good for cancer immunotherapy | Q84573840 | ||
Mechanisms of foxp3+ T regulatory cell-mediated suppression | Q29615842 | ||
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells | Q30080038 | ||
CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells | Q30480094 | ||
Sensing pathogens and tuning immune responses | Q34308011 | ||
Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. | Q34504134 | ||
Control of regulatory T cell lineage commitment and maintenance | Q34658594 | ||
Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer | Q34843832 | ||
Plasticity of CD4+ T cell lineage differentiation. | Q34982725 | ||
Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion | Q35125791 | ||
T(H)17 cells in tumour immunity and immunotherapy. | Q35623903 | ||
Transforming growth factor beta blocks Tec kinase phosphorylation, Ca2+ influx, and NFATc translocation causing inhibition of T cell differentiation | Q36370893 | ||
IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity | Q36384826 | ||
Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells | Q36399686 | ||
Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response | Q36402967 | ||
PD-1 and its ligands in T-cell immunity | Q36791446 | ||
Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. | Q36858877 | ||
A comparison of low-dose cyclophosphamide treatment with artemisinin treatment in reducing the number of regulatory T cells in murine breast cancer model. | Q39940483 | ||
Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment | Q40130406 | ||
PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. | Q42017650 | ||
Modulation of dendritic cell function by naive and regulatory CD4+ T cells | Q42494637 | ||
Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells | Q50095546 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | immunization | Q1415366 |
P304 | page(s) | e27289 | |
P577 | publication date | 2011-11-08 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Up-regulation of Th17 cells may underlie inhibition of Treg development caused by immunization with activated syngeneic T cells | |
P478 | volume | 6 |
Q36024806 | An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection. |
Q51282749 | Clinical study of total glucosides of paeony for the treatment of diabetic kidney disease in patients with diabetes mellitus. |
Q39270453 | Harnessing antitumor immunity: Employment of tumor recall antigens to optimize the inflammatory response to cancer |
Q37360516 | Involvement of P2X7 receptor signaling on regulating the differentiation of Th17 cells and type II collagen-induced arthritis in mice |
Q34290857 | Nizatidine, a small molecular compound, enhances killed H5N1 vaccine cell-mediated responses and protects mice from lethal viral challenge |
Q49203850 | Pir-B inhibits the DC function and disturbs the Th17/Treg balance in lung cancer murine model |
Q50285516 | The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions |
Search more.